Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. (Q37207653)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602567%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

review article

1 reference

title

Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602567%20AND%20SRC:MED&resulttype=core&format=json

eradication of infectious diseases

10 January 2020

main subject

HIV

0 references

anti-retroviral agent

0 references

1 reference

2

Robert F Siliciano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602567%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Lin Shen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602567%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

English

0 references

publication date

1 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602567%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

number of pages

7

1 reference

The Journal of Allergy and Clinical Immunology

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602567%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602567%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

22-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602567%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602567%20AND%20SRC:MED&resulttype=core&format=json

Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands

10 January 2020

cites work

1 reference

12 December 2020

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

12 December 2020

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

12 December 2020

The multifactorial nature of HIV-1 latency

1 reference

12 December 2020

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

12 December 2020

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

12 December 2020

Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus

1 reference

12 December 2020

Viral dynamics and anti-viral pharmacodynamics: rethinking in vitro measures of drug potency

1 reference

12 December 2020

Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1.

1 reference

12 December 2020

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

1 reference

12 December 2020

Regulation of HIV-1 latency by T-cell activation.

1 reference

12 December 2020

Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART

1 reference

12 December 2020

Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells

1 reference

12 December 2020

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

1 reference

12 December 2020

Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads

1 reference

12 December 2020

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

1 reference

12 December 2020

New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma

1 reference

12 December 2020

In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.

1 reference

12 December 2020

Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs

1 reference

12 December 2020

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

12 December 2020

The inhibitory quotient.

1 reference

12 December 2020

Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy

1 reference

12 December 2020

Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy

1 reference

12 December 2020

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

1 reference

12 December 2020

Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy

1 reference

12 December 2020

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

1 reference

12 December 2020

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

12 December 2020

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

1 reference

12 December 2020

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

1 reference

12 December 2020

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

1 reference

12 December 2020

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy

1 reference

12 December 2020

The role of mononuclear phagocytes in HTLV-III/LAV infection

1 reference

12 December 2020

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

12 December 2020

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

12 December 2020

Experimental approaches to the study of HIV-1 latency

1 reference

12 December 2020

Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

1 reference

12 December 2020

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

1 reference

12 December 2020

A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs

1 reference

12 December 2020

Clinical pharmacodynamics of HIV-1 protease inhibitors: use of inhibitory quotients to optimise pharmacotherapy

1 reference

12 December 2020

In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

1 reference

12 December 2020

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

1 reference

12 December 2020

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

12 December 2020

Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy

1 reference

12 December 2020

Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates.

1 reference

12 December 2020

Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads

1 reference

12 December 2020

Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1.

1 reference

12 December 2020

Quantitative image analysis of HIV-1 infection in lymphoid tissue.

1 reference

12 December 2020

An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults

1 reference

12 December 2020

The inhibitory quotient. A method for interpreting minimum inhibitory concentration data

1 reference

12 December 2020

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

1 reference

12 December 2020

10.1016/J.JACI.2008.05.033

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602567%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602567%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference